By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoResponse 

909 Fannin Street
Suite 2100
Houston  Texas  77024  U.S.A.
Phone: 206-805-1600 Fax: 206-805-1699


SEARCH JOBS

OncoResponse, a privately held immuno-oncology company, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to the discovery of cancer therapeutics.

OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer, thereby extending the benefit of immunotherapy to a greater number of patients.

YEAR FOUNDED:

2015

LEADERSHIP:

CEO: Clifford J. Stocks

CSO: Kristine Swiderek, Ph.D.

CFO: Russ Hawkinson

TECHNOLOGY:

Please click here for OncoResponse's technology.


Key Statistics


Email: info@oncoresponseinc.com
Ownership: Private

Web Site: OncoResponse
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->